Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001933414-25-000009
Filing Date
2025-02-12
Accepted
2025-02-12 09:22:29
Documents
85
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mlys-20241231.htm   iXBRL 10-K 1488302
2 EX-10.12 mlysfy2410kex1012.htm EX-10.12 261333
3 EX-19.1 mlysfy2410kex191.htm EX-19.1 50729
4 EX-23.1 mlysfy2410kex231.htm EX-23.1 3679
5 EX-31.1 mlysfy2410kex311.htm EX-31.1 9813
6 EX-31.2 mlysfy2410kex312.htm EX-31.2 9750
7 EX-32.1 mlysfy2410kex321.htm EX-32.1 5053
8 EX-32.2 mlysfy2410kex322.htm EX-32.2 4957
14 mlys-20241231_g1.jpg GRAPHIC 166569
15 mlys-20241231_g10.jpg GRAPHIC 552652
16 mlys-20241231_g11.jpg GRAPHIC 34244
17 mlys-20241231_g2.jpg GRAPHIC 671014
18 mlys-20241231_g3.jpg GRAPHIC 386220
19 mlys-20241231_g4.jpg GRAPHIC 537942
20 mlys-20241231_g5.jpg GRAPHIC 1637794
21 mlys-20241231_g6.jpg GRAPHIC 148220
22 mlys-20241231_g7.jpg GRAPHIC 1449669
23 mlys-20241231_g8.jpg GRAPHIC 393695
24 mlys-20241231_g9.jpg GRAPHIC 631115
  Complete submission text file 0001933414-25-000009.txt   22205035

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20241231.xsd EX-101.SCH 37432
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20241231_cal.xml EX-101.CAL 43246
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20241231_def.xml EX-101.DEF 167359
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20241231_lab.xml EX-101.LAB 542398
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20241231_pre.xml EX-101.PRE 372086
88 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20241231_htm.xml XML 545279
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41614 | Film No.: 25612429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)